Gene Editing: The Present And Future

The transcript covers a discussion on the ethical implications of CRISPR technology, particularly in light of the birth of gene-edited babies in China. It highlights the need for international regulations, the role of public engagement, and the challenges of balancing scientific progress with ethical considerations. The conversation also touches on the business aspects of CRISPR and the conflicts that arise from patent disputes.

What was the speaker's initial reaction to the announcement of gene-edited babies in China?

• Support for the scientist's actions

• Indifference to the news

• Surprise and concern about ethical implications

• Excitement about the scientific breakthrough

Who did the speaker first consult after learning about the gene-edited babies?

• David Baltimore, a Nobel laureate

• A fellow scientist

• The media

• A government official

What is one of the main challenges in regulating gene editing technology?

• The simplicity of the technology

• The complexity of the technology

• High cost of implementation

• Lack of interest from scientists

What does the speaker believe is necessary for responsible use of gene editing technology?

• Public opinion polls

• Strict international guidelines

• Complete freedom for scientists

• Government control

What is the speaker's stance on gene editing of embryos?

• It should be used to improve humanity

• It should not be used currently

• It should be used only for serious diseases

• It should be used freely

What does the speaker suggest as a more effective approach than a moratorium on gene editing?

• Complete ban on research

• Clear international regulations

• Public voting on the issue

• Leaving it to individual countries

What is one potential benefit of gene editing mentioned by the speaker?

• Creating designer babies

• Curing genetic diseases

• Enhancing physical abilities

• Increasing intelligence

How does the speaker view the relationship between academia and industry in CRISPR research?

• As completely separate entities

• As increasingly collaborative

• As competitive rivals

• As irrelevant to each other

What is the speaker's opinion on the impact of patent disputes on scientific collaboration?

• They have improved collaboration

• They have complicated but not stopped collaboration

• They have had no impact

• They have severely hindered collaboration

What is the speaker's view on the current state of CRISPR technology?

• It is still developing and requires careful handling

• It is only useful in agriculture

• It is fully developed and ready for widespread use

• It is too dangerous to pursue further